Chrysanthemum indicum

About: Chrysanthemum indicum is a research topic. Over the lifetime, 465 publications have been published within this topic receiving 4925 citations. The topic is also known as: Indian chrysanthemum.

Drug-smelling plant air clean fluid for purifying environment and reinforcing respiratory system

Abstract: The invention discloses a drug-smelling plant air clean fluid for purifying environment and reinforcing a respiratory system. The air clean fluid is prepared by using an eupatorium fortunei distillate and a chrysanthemum indicum distillate as carriers and adding a natural drug-smelling plant volatile oil. The air clean liquid in a preferable scheme contains the following components by volume percentage: 20-26% of eupatorium fortunei distillate, 70-78% of chrysanthemum indicum distillate, 0.8-3.5% of eupatorium fortune volatile oil, 0.5-2.5% of chrysanthemum indicum volatile oil, 0.2-2.0% of thymus mongolicus volatile oil, and 0.5-2.0% of foliumartemisiae argyi volatile oil. The effective components of the air clean liquid in the invention all prepared from natural plants, have functions of purifying air and environment and reinforcing the respiratory system, are safe, have no toxic side effects, and have good drug smelling.

Effect of culture media and growth regulators on in vitro propagation of Chrysanthemum indicum L.

Abstract: A rapid shoot multiplication of Chrysanthemum(Chrysanthemum indicum L.).has been optimized in the present study. Apical meristems were used as explants and inoculated on MS media supplemented with various concentrations of growth regulators. The effects of different phytohormones (BAP, NAA, IAA and IBA) were tested for their effect on enhancement of shoot multiplication. MS medium fortified with BAP 1.0 + IAA 0.1 mg/l had a promotory effect on the initiation and multiplication of micro shoots. The optimum shoot formation response was 82% with 5.20 average number of shoots per explants and acquired maximum length of 4.9 cm. Rooting study revealed that MS medium supplemented with IBA 0.1 mg/l were proved to be superior with maximum (85%) rooting, 2.7 roots per explants and 2.5 cm root length. Then plantlets were shifted in Green house for acclimatization.

Analgesic activity of the aqueous fraction from the ethanolic extract of Chrysanthemum indicum in mice.

Abstract: The aqueous fraction (AF) of an ethanolic extract from Chrysanthemum indicum was evaluated for analgesic activity in mice using chemical and thermal models of nociception. Given orally, AF at doses of 300 and 600 mg/kg produced significant inhibitions on chemical nociception induced by intraperitoneal acetic acid, subplantar formalin/capsaicin injections and on thermal nociception in the tail-flick test and in the hot plate test. In the pentobarbital sodium-induced sleeping time test and the open-field test, AF neither significantly enhanced the pentobarbital sodium-induced sleeping time nor impaired the motor performance, indicating that the observed analgesic activity was unlikely due to sedation or motor abnormality. In a measurement of core body temperature, AF did not affect temperature within 80 min. Moreover, the effective dose (600 mg/kg) also showed no toxicity within 7 days. These results suggested further that AF produced analgesic activity possibly related to the flavonoid glycosides and phenolic glycosides in this fraction.

Hypouricemic Effects of Chrysanthemum indicum L. and Cornus officinalis on Hyperuricemia-Induced HepG2 Cells, Renal Cells, and Mice

Abstract: Hyperuricemia, abnormally excess accumulation of uric acid, is caused by an imbalance between the production and excretion of uric acid and is a major cause of gout. We compared the effects of extracts from Chrysanthemum indicum L. (Ci) and Cornus officinalis Siebold and Zucc. (Co) on hyperuricemia, both individually and in combination (FSU-CC), using hypoxanthine-treated human liver cancer (HepG2) cells, primary mouse renal proximal tubule cells, and potassium oxonate induced hyperuricemic mice. The Ci contained 7.62 mg/g luteolin and 0 mg/g loganin, Co contained 0 mg/g luteolin and 4.90 mg/g loganin, and FSH-CC contained 3.95 mg/g luteolin and 2.48 mg/g loganin. We found that treatment with Ci, Co, and FSU-CC suppressed the activity of xanthine oxidase and mRNA expression of xanthine dehydrogenase while inducing an increase in the expression levels of the organic anion transporter 1 (OAT1) and organic anion transporter 3 (OAT3) proteins and a decrease in the expression levels of glucose transporter 9 (GLUT9) and urate transporter 1 (URAT1) proteins. Particularly, treatment and supplementation with FSU-CC showed stronger effects than those of supplementation with either Ci or Co alone. We observed that the excretion of creatinine and uric acid in the combination of Ci and Co was higher than that observed in their individual supplementations and was similar to that of the normal group. Therefore, our data suggest that a combination of Ci and Co may potentially be used for the development of effective natural anti-hyperuricemic functional foods.